CrushSCI.com
97.3Average days
99Median days
50Fastest days
160Longest days
4272025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

92 days

Impact of generic market entry on the consumption of last-resort antibiotics in six European countries

Authors
Caroline Schweizer; Sebastian Weis; Evelina Tacconelli; Stephan Harbarth; Mathias W. Pletz; Stefan Hagel; Miriam KesselmeierShow moreShow less
Affiliations
Institute of Infectious Diseases and Infection Control, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany; Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena, Germany; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy; Division of Infection Prevention and Control, WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland; Institute of Medical Statistics, Computer and Data Sciences (IMSID), Jena University Hospital – Friedrich Schiller University Jena, Jena, GermanyShow moreShow less
Source PDF DOI Publisher page
117 days

Blinded two-year longitudinal evaluation of SARS-CoV-2 antigenemia in long COVID

Authors
Lourdes Mateu; Louise L. Hansen; Joao Pedro Carmezim; Cora Loste; Tommaso Francesco Aiello; Gemma Lladós; Jose Ramon Santos; Edwards Pradenas; Benjamin Trinité; Cristina Herrero; Anna Garcia; Anna Gervassi; Teresa Puig; Eulàlia Grau; Jorge Carrillo; Julià Blanco; Gustavo H. Kijak; Cristian Tebé; Roger Paredes; David R. Walt; Marta MassanellaShow moreShow less
Affiliations
Department of Infectious Diseases, Hospital Germans Trias i Pujol, Badalona, Catalonia, Spain; Fundació Lluita contra les Infeccions, Badalona, Spain; Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain; Universitat de Vic – Universitat Central de Catalunya, Vic, Catalonia, Spain; Red Española de Investigación en Covid Persistente (REICOP), Madrid, Spain; Department of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA; Biostatistics Support and Research Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP), Catalonia, Spain; IrsiCaixa, Badalona, Barcelona, Spain; CIBERINFEC, Madrid, Spain; AstraZeneca, Gaithersburg, MD, USA; Universitat Politècnica de Catalunya – BarcelonaTech, Terrassa, Catalonia, SpainShow moreShow less
Source PDF DOI Publisher page
59 days

Glucocorticoid use and candidemia: results from a nationwide case-control study

Authors
Cæcilie Leding; Alessandra Meddis; Jon Gitz Holler; Karen Marie Thyssen Astvad; Thomas BenfieldShow moreShow less
Affiliations
Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark; Department of Public Health, University of Copenhagen, Copenhagen, Denmark; Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital - North Zealand, Hillerød, Denmark; Unit of Mycology, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkShow moreShow less
Source PDF DOI Publisher page
50 days

Diagnostic accuracy and potential resource savings of pooled sputum testing with Xpert MTB/RIF Ultra for tuberculosis among adults in Vietnam: a cross-sectional study

Authors
Han Thi Nguyen; Andrew James Codlin; Luan Nguyen Quang Vo; Nga Thi Thuy Nguyen; Rachel Forse; Ha Thi Minh Dang; Lan Huu Nguyen; Hoa Binh Nguyen; Luong Van Dinh; Ha Thu Doan; Hung Van Nguyen; Jacob Creswell; Tushar Garg; Ana Isabel Cubas Atienzar; Rachel Louise Byrne; Vibol Iem; S Bertie Squire; Lina Davies Forsman; Tom WingfieldShow moreShow less
Affiliations
Research Department, FIT RD Social Enterprise Company Limited (FIT RD), Hanoi, Vietnam; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Friends for International TB Relief, Hanoi, Vietnam; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam; Vietnam National Lung Hospital, Hanoi, Vietnam; Department of Medical Microbiology and Infection Control, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam; Stop TB Partnership, Geneva, Switzerland; Centre for Tuberculosis Research, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Centre for Tuberculosis Research, Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK; Tropical and Infectious Diseases Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UKShow moreShow less
Source PDF DOI Publisher page
99 days

Defining the unbound target exposure of teicoplanin, Part 1: Insights from the hollow-fibre system

Authors
Jaap W.A. Mouton; Jelmer Raaijmakers; Sebastian T. Tandar; Nynke G.L. Jager; Rob ter Heine; Roger J.M. Brüggemann; J.G. Coen van Hasselt; Jakko van IngenShow moreShow less
Affiliations
Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The NetherlandsShow moreShow less
Source PDF DOI Publisher page
99 days

Defining the unbound target exposure of teicoplanin, Part 2: Dose individualization through population pharmacokinetic modelling

Authors
Jaap W.A. Mouton; Nynke G.L. Jager; Eveline Wallenburg; Jeroen A. Schouten; Walter J.F.M. van der Velden; Lenneke F.J. van Groningen; Nicole M.A. Blijlevens; Peter Pickkers; J.G. Coen van Hasselt; Jakko van Ingen; Rob ter Heine; Roger J.M. BrüggemannShow moreShow less
Affiliations
Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The Netherlands; Department of Pharmacy, Elisabeth-Tweesteden Ziekenhuis, Tilburg, The Netherlands; Department of Intensive Care, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The Netherlands; Department of Hematology, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Department of Medical Microbiology, Radboudumc, Research Institute for Medical Innovation, Nijmegen, The NetherlandsShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CLINICAL MICROBIOLOGY AND INFECTION take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for CLINICAL MICROBIOLOGY AND INFECTION. The fastest paper went from submission to acceptance in 50 days (Diagnostic accuracy and potential resource savings of pooled sputum testing with Xpert MTB/RIF Ultra for tuberculosis among adults in Vietnam: a cross-sectional study, received 2026-03-31, accepted 2026-05-20); the slowest took 160 days. The average is 97.3 days and the median is 99 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.